A Study to Investigate the Effects of GSK598809 in Newly Abstinent Nicotine-dependent Subjects

Trial Profile

A Study to Investigate the Effects of GSK598809 in Newly Abstinent Nicotine-dependent Subjects

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 18 Feb 2016

At a glance

  • Drugs GSK 598809 (Primary)
  • Indications Smoking withdrawal; Substance-related disorders
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 12 Feb 2016 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 28 Oct 2014 Status changed from withdrawn prior to enrolment to discontinued as reported by ClinicalTrials.gov record.
    • 15 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top